Bio-Techne (NASDAQ: TECH) reported Q1 EPS of $1.83, $0.11 better than the analyst estimate of $1.72. Revenue for the quarter came in at $257.7 million versus the consensus estimate of $252.42 million.

For earnings history and earnings-related data on Bio-Techne (TECH) click here.